Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Fangzhou Inc. ( (HK:6086) ) is now available.
Fangzhou Inc. has issued a positive profit alert, projecting 2025 revenue of approximately RMB3.50 billion to RMB3.55 billion, about 30% higher than the prior year, and a swing to a net profit of RMB7 million to RMB10 million from a net loss before tax of RMB854.9 million in 2024. Management attributes the top-line expansion to continued growth across its consumer-facing healthcare platform, driven by rising patient and doctor engagement, while the return to profitability is being supported by both higher revenue and lower equity-settled share-based expenses, though the figures remain preliminary and unaudited, prompting the company to caution investors until final results are released by the end of March 2026.
The most recent analyst rating on (HK:6086) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Fangzhou Inc. stock, see the HK:6086 Stock Forecast page.
More about Fangzhou Inc.
Fangzhou Inc., incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, operates consumer-facing business segments in the healthcare sector, focusing on attracting patients and doctors to its platform-driven services.
Average Trading Volume: 9,794,344
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$3.79B
Learn more about 6086 stock on TipRanks’ Stock Analysis page.